Kura Oncology, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Kura Oncology, Inc. (KURA)
Last kura oncology, inc. earnings: 2/25 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.kuraoncology.com/investor-relations
Company Research
Source: Yahoo! Finance
Kura Oncology, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Market Positioning Achieved first product revenue of $2.1 million from Comzifty in late 2025, marking the company's transition to a commercial-stage biopharmaceutical entity. Management attributes early launch success to Comzifty's differentiated safety profile, specifically citing a single boxed warning versus multiple warnings for competitors. Strategic positioning focuses on 'simplicity and combinability,' emphasizing once-daily dosing and the lack of required azole dose adjustments in medically complex AML patients. The company is executing a 'first-to-frontline' strategy, asserting that long-term class leadership will be determined by the ability to combine with standard-of-care backbones like venetoclax and 7+3 chemotherapy. Operational scale-up included deploying a specialized sales force targeting 4,000 hematology professionals and securing NCCN Category 2A recommendation within one w
Show less
Read more
Impact Snapshot
Event Time:
KURA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KURA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KURA alerts
High impacting Kura Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
KURA
News
- Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Kura Oncology: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Kura Oncology (KURA) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=KURA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" toMarketBeat
KURA
Earnings
- 3/5/26 - Miss
KURA
Sec Filings
- 3/5/26 - Form 10-K
- 3/5/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- KURA's page on the SEC website